Raloxifene dimesylate hydrochloride

CAS: 84449-85-4

Ref. 3D-JDA44985

Produktinformation

• Name: Raloxifene dimesylate hydrochloride
• Synonyme: Methanone, [6-[(methylsulfonyl)oxy]-2-[4-[(methylsulfonyl)oxy]phenyl]benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]-, hydrochloride (1:1), [6-[(Methylsulfonyl)oxy]-2-[4-[(methylsulfonyl)oxy]phenyl]benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]methanone hydrochloride (1:1), Methanone, [6-[(methylsulfonyl)oxy]-2-[4-[(methylsulfonyl)oxy]phenyl]benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]-, hydrochloride

Beschreibung

Raloxifene dimesylate hydrochloride is a drug product that is a synthetic estrogen. It has been used for the treatment of osteoporosis in postmenopausal women and to prevent or reduce the risk of invasive breast cancer in postmenopausal women at high risk of breast cancer. Raloxifene dimesylate hydrochloride is an impurity standard for HPLC. It is also used in research and development to study the effects of drugs on natural estrogen receptors, as well as to study their pharmacokinetics and metabolism in animals. Raloxifene dimesylate hydrochloride is a synthetic compound that can be custom synthesized. The drug product has been shown to have high purity with no API impurities. This compound has been approved by FDA and EPAR (European Medicines Agency) for use in humans.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 666.20 g/mol
• Formel: C₃₀H₃₂ClNO₈S₃
• Reinheit: Min. 95%